Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

2.5K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
2.5K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

105
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
105
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

6.2K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
6.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

7
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
7
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

10
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
10
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

165
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
165

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical Implementation of Organ Donation Following Medical Assistance in Dying: Recommendations of the Ethics Committee of the Transplantation Society.

Transplantation·2026
Same author

Rethinking procurement biopsy in donors with normal renal function: A barrier to kidney utilization without survival benefit.

World journal of transplantation·2026
Same author

Reply: Validation of MELD 3.0 in 2 centers from different continents.

Hepatology communications·2026
Same author

Use of En Bloc Kidney Allografts for Pediatric Kidney-Alone and Multiorgan Transplant Recipients in the United States.

Pediatric transplantation·2026
Same author

Waitlist mortality in liver transplantation: Understanding metrics, regulatory implications, and clinical management strategies.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Frailty Increases Hospitalization Rates in an Ambulatory Cohort of Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease 3 Prospective Cohort.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Related Experiment Video

Updated: Oct 6, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.6K

Building a Utility-based Liver Allocation Model in Preparation for Continuous Distribution.

Catherine E Kling1,2, James D Perkins1,2, Scott W Biggins2,3,4

  • 1Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA.

Transplantation Direct
|January 20, 2022
PubMed
Summary
This summary is machine-generated.

Optimizing liver allocation using mathematical models significantly improves long-term graft survival. This new system prioritizes donor-recipient quality matching, enhancing survival rates and reducing graft losses in liver transplantation.

More Related Videos

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

529
Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure

Published on: August 14, 2017

14.9K

Related Experiment Videos

Last Updated: Oct 6, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.6K
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

529
Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure

Published on: August 14, 2017

14.9K

Area of Science:

  • Transplantation research
  • Medical optimization
  • Organ allocation systems

Background:

  • Current US liver allocation prioritizes sickest patients, potentially compromising long-term graft survival.
  • A continuous distribution model aims to incorporate posttransplant survival measures.
  • Existing systems may not fully optimize donor-recipient matching for long-term outcomes.

Purpose of the Study:

  • To develop and evaluate a liver allocation system maximizing long-term graft survival.
  • To utilize mathematical optimization for matching donor and recipient quality.
  • To assess the impact of a quality-based allocation model on posttransplant outcomes.

Main Methods:

  • Utilized Cox proportional hazard models with Organ Procurement and Transplantation Network data (2008-2012).
  • Categorized donors and recipients into 5 risk groups for graft loss.
  • Employed a mixed integer programming optimization model to define allocation rules maximizing 5- and 8-year graft survival.

Main Results:

  • Mathematical optimization improved 5-year survival by 7.5% and 8-year survival by 9% compared to historical data.
  • This model avoided 2271 (5-year) and 2725 (8-year) graft losses.
  • Recipient survival within quality groups strongly depends on donor quality; high-risk candidates (groups 4-5) were not transplanted.

Conclusions:

  • A liver allocation model incorporating donor and recipient quality significantly enhances long-term graft survival.
  • The interaction between donor and recipient quality is a critical factor in predicting graft survival.
  • Findings support the integration of these optimized allocation strategies into continuous distribution models.